Skip to main content
Home
Breast Cancer ICYMI
  • FULL MENUFULL MENU Presented by
    • MDedge
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    Clinical Topics

    October 5, 2022

    Is early-onset cancer an emerging global epidemic?

    October 5, 2022
    Megan Brooks
    Megan Brooks
    October 5, 2022
    Breast Cancer ICYMI
    September 30, 2022

    Cost paramount when choosing metastatic breast cancer treatment

    September 30, 2022
    Sharon Worcester, MA
    Sharon Worcester, MA
    September 30, 2022
    Breast Cancer ICYMI
    September 22, 2022

    Genetic tests create treatment opportunities and confusion for breast cancer patients

    September 22, 2022
    Michelle Andrews, Kaiser Health News
    Michelle Andrews, Kaiser Health News
    September 22, 2022
    Breast Cancer ICYMI
    September 15, 2022

    Time to cancer diagnoses in U.S. averages 5 months

    September 15, 2022
    Jim Kling
    Jim Kling
    September 15, 2022
    ESMO: European Society for Medical Oncology
    Breast Cancer ICYMI
    September 13, 2022

    Sex is still a taboo subject for patients with breast cancer

    September 13, 2022
    Cristina Ferrario
    Cristina Ferrario
    September 13, 2022
    Breast Cancer ICYMI
    August 29, 2022

    Tumor-bed radiotherapy boost reduces DCIS recurrence risk

    August 29, 2022
    Neil Osterweil
    Neil Osterweil
    August 29, 2022
    Breast Cancer ICYMI
    August 26, 2022

    In denial: When patients don’t want to believe they have cancer

    August 26, 2022
    Christina Frangou
    Christina Frangou
    August 26, 2022
    Breast Cancer ICYMI
    August 18, 2022

    Lung adverse effects in patients taking trastuzumab deruxtecan

    August 18, 2022
    Pam Harrison
    Pam Harrison
    August 18, 2022
    Breast Cancer ICYMI
    Read More

    Conference Coverage

    November 9, 2023

    Particulate pollution increases the risk for breast cancer

    November 9, 2023
    Aude Lecrubier
    Aude Lecrubier
    November 9, 2023
    ESMO: European Society for Medical Oncology
    Breast Cancer ICYMI
    November 8, 2023

    T-DXd benefits persist for HER2-low breast cancer

    November 8, 2023
    Sharon Worcester, MA
    Sharon Worcester, MA
    November 8, 2023
    ESMO: European Society for Medical Oncology
    Breast Cancer ICYMI
    November 2, 2023

    Omitting surgery may be safe in early BC after neoadjuvant pCR

    November 2, 2023
    M. Alexander Otto
    M. Alexander Otto
    November 2, 2023
    ESMO: European Society for Medical Oncology
    Breast Cancer ICYMI
    October 25, 2023

    Dato-DXd trumps chemo in advanced HR+/HER2– breast cancer

    October 25, 2023
    Neil Osterweil
    Neil Osterweil
    October 25, 2023
    ESMO: European Society for Medical Oncology
    Breast Cancer ICYMI
    October 25, 2023

    The sobering facts about alcohol and cancer

    October 25, 2023
    Megan Brooks
    Megan Brooks
    October 25, 2023
    ESMO: European Society for Medical Oncology
    Breast Cancer ICYMI
    October 22, 2023

    ICIs improve pCR rates in early ER+/HER2– breast cancer

    October 22, 2023
    Neil Osterweil
    Neil Osterweil
    October 22, 2023
    ESMO: European Society for Medical Oncology
    Breast Cancer ICYMI
    October 22, 2023

    No benefit to adding ICI to chemo in triple-negative breast cancer: study

    October 22, 2023
    Neil Osterweil
    Neil Osterweil
    October 22, 2023
    ESMO: European Society for Medical Oncology
    Breast Cancer ICYMI
    October 22, 2023

    Remote symptom monitoring in advanced cancer improves quality of life

    October 22, 2023
    Megan Brooks
    Megan Brooks
    October 22, 2023
    ESMO: European Society for Medical Oncology
    Breast Cancer ICYMI
    Read More

    Expert Perspectives

    July 10, 2023

    Circulating Tumor DNA Testing and Liquid Biopsy: The Future for Precision Medicine and Guided Targeted Therapy for Breast Cancer?

    July 10, 2023
    Adam Brufsky, MD, PhD
    Adam Brufsky, MD, PhD
    July 10, 2023
    Breast Cancer ICYMI
    May 2, 2023

    Antibody Drug Conjugates: a growing field of targeted therapy for breast cancer

    May 2, 2023
    Aditya Bardia, MD, MPH
    Aditya Bardia, MD, MPH
    May 2, 2023
    Breast Cancer ICYMI
    March 23, 2023

    Antibody-Drug Conjugates: Targeted Treatments Providing Hope for Patients With Breast Cancer

    March 23, 2023
    Sara A. Hurvitz, MD
    Sara A. Hurvitz, MD
    March 23, 2023
    Breast Cancer ICYMI
    January 5, 2023

    Year in Review: How Targeted Drug Therapies Have Expanded Breast Cancer Treatment Options in 2022

    January 5, 2023
    Kevin Kalinsky, MD, MS
    Kevin Kalinsky, MD, MS
    January 5, 2023
    Breast Cancer ICYMI
    Read More

    MD-IQ

    Patient Preferences in Breast Cancer Management

    Breast Cancer Surgery

    Atypical Ductal Hyperplasia

    Breast Cancer Exercise Interventions

    More

    Clinical Edge Journal Scan

    November 29, 2023

    Commentary: Vaginal Estrogen Therapy, ILC, And Oral Estrogen Receptor Degraders In Breast Cancer, December 2023

    November 29, 2023
    Yara Abdou, MD
    Yara Abdou, MD
    November 29, 2023
    Breast Cancer ICYMI
    November 14, 2023

    Meta-analysis shows benefits of capecitabine-based chemo in early TNBC

    November 14, 2023
    November 14, 2023
    Breast Cancer ICYMI
    November 14, 2023

    Regional nodal irradiation may not be needed after preoperative systemic therapy in HER2+ BC

    November 14, 2023
    November 14, 2023
    Breast Cancer ICYMI
    November 14, 2023

    Taxanes followed by PLD show promise in metastatic BC under real-world settings

    November 14, 2023
    November 14, 2023
    Breast Cancer ICYMI
    Read More

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    FULL MENU FULL MENU Presented by
    • FULL MENU FULL MENU

      More

      • MDedge

    More

    • MDedge